Opinion
Video
Author(s):
Pashtoon Murtaza Kasi, MD, MS, discusses MRD testing practices in the community oncology setting and provides recommendations on the integration of MRD testing into clinical practice.
BTK Inhibitor–Based Combinations Represent the Future of MCL Management
Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
The Microbiome and Colon Cancer: Dietary Influence on Incidence, Morbidity, and Mortality
Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC
GRANITE Plus ICIs and Bevacizumab/Chemo Shows Improved PFS Trend in MSS mCRC
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors
Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma
Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN
Dr Kumethaker on CSF Tumor Detection in Breast Cancer or NSCLC with Leptomeningeal Disease
Dr Schiff on PFS and OS Data With Temozolomide Plus Radiation in Grade II Glioma